It’s always nice to start the week off with some good news and we got this week off to a great start with some great news. ViaCyte has been given the green light to start a clinical trial with its therapy for type 1 diabetes, a program we are funding.ViaCyte applied to the Food and … Continue reading CIRM funded therapy for type 1 diabetes gets FDA approval for clinical trial